Phase II trial of a doxorubicin/docetaxel doublet for locally advanced and metastatic breast cancer: results from national surgical adjuvant breast and bowel project trial BP-57.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples